China Companion Animal Health Market is set to reach US$ 3.7 billion by 2030, at a strong CAGR of 11.4%.Asia Pacific holds the market with 24% market share.

The China Companion Animal Health Market reached US$ 1.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 3.7 billion by 2030. The China companion animal health market is expected to exhibit a CAGR of 11.4% during the forecast period (2024-2031).

The China Companion Animal Health market focuses on veterinary care, pet nutrition, and preventive products, driven by rising pet ownership, urbanization, and increasing awareness of animal wellness across major cities.

DataM Intelligence unveils its latest report on the " China Companion Animal Health Market size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/china-companion-animal-health-market?prtk

China: Key Industry Developments
✅ December 2025: PETKIT launched the Purobot Crystal Duo, the world's first open-top automatic litter box with AI camera for urological health tracking, featuring urination pH monitoring and stool analysis to detect early pet health issues.​
The product garnered over 8,000 pre-orders shortly after announcement, reflecting strong demand for AI-driven companion animal health innovations in urban China.​

✅ September 2025: USDA reported China's pet food market poised for 6-8% growth in high-end functional products emphasizing balanced nutrition and health support, driven by rising pet owner spending on supplements and medicines.​
U.S. pet food exports to China reached a record $296.6 million in 2024, underscoring sustained preference for premium health-focused imports amid expanding companion animal care.​

✅ August 2025: Pet Fair Asia showcased over 500 new global pet health products, including nutrition, diagnostics, and wellness items for companion animals, highlighting China's booming demand in preventive care and specialized treatments.​
The event featured dedicated halls for pet nutrition and feline health, aligning with trends in pet humanization and rising zoonotic disease awareness.

📌 China Companion Animal Health Market 2025-26 M&A Deals
→ In May 2025, GL events, a France‐based integrated events group, acquired a 69% stake in the East West Small Animals Clinical Veterinary Surgeons Conference (WESAVC), the organiser of China's leading veterinary equipment and companion animal health exhibition in Xiamen. This acquisition bolsters GL events' presence in the Chinese companion animal health ecosystem by strengthening its role in veterinary industry events and knowledge platforms.

→ In March 2025, New Ruipeng Pet Healthcare Group announced the acquisition of a 60% stake in a Shanghai‐based companion animal diagnostics laboratory, expanding its in‐clinic testing services and diagnostics capabilities within China's burgeoning pet medical services sector

China Companion Animal Health Market Drivers:-

⏩ Urban and younger Chinese increasingly prefer pets over traditional family expansion, driven by lifestyle changes and declining fertility.

⏩ Pet ownership has surged, and current estimates show tens of millions of households owning companion animals - especially dogs and cats - with long‐term upward demand projected for healthcare services.

⏩ Demographic trends indicate that pets are living longer and aging, increasing demand for chronic care, diagnostics, and advanced treatments - e.g., aging rates of pet populations have risen significantly.

⏩ China's growing middle class has more disposable income, reflected in higher expenditure on pet wellness, annual check‐ups, and advanced therapeutics.

⏩ Companion animal health as a segment is transitioning from reactive care (treatment of illness) to preventive care and chronic disease management, mirroring human healthcare spending patterns.

⏩ Expansion of specialized veterinary clinics, hospitals, referral centers, and diagnostic labs across major cities increases service accessibility, especially in Tier 1 and Tier 2 regions.

⏩ Increased veterinary education and professionalization enhances the quality and range of services available, catalyzing both demand and willingness to pay.

⏩ Tele‐vet consultations, AI‐assisted diagnostics, wearable health trackers, and e‐commerce sales are growing rapidly, broadening access and personalizing care options.

⏩ Diagnostic tools and advanced imaging are becoming more affordable and widespread, increasing early disease detection and treatment effectiveness.

⏩ Chinese authorities are strengthening animal health governance, vaccination standards, and disease control measures, encouraging professional care adoption.

⏩ Partnerships with animal welfare organizations and international bodies are enhancing awareness of preventable diseases and proper healthcare protocols.

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=china-companion-animal-health-market?prtk

China Companion Animal Health Major Players:-

Boehringer Ingelheim International GmbH, Vetoquinol, Zoetis Services LLC, Elanco, MSD Animal Health China (Merck & Co. Inc.), China Animal Husbandry Group, Virbac, Jinyu Bio-technology Co., Ltd., Ceva and Bimeda, Inc. among others.

Key players highlights:-

Zoetis Services LLC - A leading global animal health company with a broad portfolio of vaccines, parasiticides and pharmaceuticals; China is one of its fastest‐growing markets and among top regional contributors globally. Zoetis holds a strong competitive position in China's pet healthcare segment driven by diversified products.

Boehringer Ingelheim International GmbH - Major multinational with significant presence in China, known for vaccines and therapeutic products; expanding through local partnerships and veterinary networks. It consistently ranks among the largest foreign players in China's companion animal health space.

Elanco Animal Health - U.S.-based animal health company offering comprehensive medicines and preventive care; actively expanding in China via e‐commerce and veterinary distribution channels. Elanco is recognized as a key competitor with broad product reach.

MSD Animal Health China (Merck & Co., Inc.) - The animal health division of Merck, providing vaccines and therapeutics; maintains a solid market footprint in China through innovation and established global brands. It is one of the top global players also active locally.

Virbac - French animal health specialist with a balanced portfolio of companion animal products including parasiticides and antibiotics; holds notable market share among international and domestic peers in China.

Regional Highlights
North America
• Holds approximately 38% of the global companion animal health market share.
• Market driven by high pet ownership, advanced veterinary infrastructure, and growing pet insurance adoption.
• Continuous investment in diagnostics, preventive care, and specialty treatments supports steady growth.

Europe
• Accounts for about 28% of the global companion animal health market share.
• Strong regulatory environment and high pet care awareness underpin market growth.
• Increased spending on preventive care and veterinary services fuels expansion.

Asia‐Pacific (including China)
• Represents roughly 24% of the global market share.
• China leads the region with rapid pet ownership growth, rising disposable income, and expanding veterinary infrastructure.
• Market development emphasizes preventive care, diagnostics, pharmaceuticals, and digital veterinary services.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/china-companion-animal-health-market?prtk

China Companion Animal Health market segmentation :

The China Companion Animal Health Market is segmented by product type, including Vaccines, Anti-Infectives, Medicinal Feed Additives, Parasiticides, Diagnostics, and others. By animal, the market covers Cats, Dogs, Equine, and other pets. By end user, it serves Veterinary Hospitals & Clinics, Homecare, and other channels, reflecting diverse demand across treatment, prevention, and pet care solutions.

Q: What is driving the growth of the China Companion Animal Health market?
A: Rising pet ownership, increased veterinary care, and demand for advanced animal health products are key growth drivers.

Q: Which segments dominate the China Companion Animal Health market?
A: Vaccines, anti-infectives, and parasiticides lead, with dogs and cats as primary end-users.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.